These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 17990842)
1. Pharmacogenetics: using DNA to optimize drug therapy. Lanfear DE; McLeod HL Am Fam Physician; 2007 Oct; 76(8):1179-82. PubMed ID: 17990842 [TBL] [Abstract][Full Text] [Related]
3. Overview of pharmacogenetics in anticoagulation therapy. Hill CE; Duncan A Clin Lab Med; 2008 Dec; 28(4):513-24. PubMed ID: 19059059 [TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics: from bench to byte. Swen JJ; Wilting I; de Goede AL; Grandia L; Mulder H; Touw DJ; de Boer A; Conemans JM; Egberts TC; Klungel OH; Koopmans R; van der Weide J; Wilffert B; Guchelaar HJ; Deneer VH Clin Pharmacol Ther; 2008 May; 83(5):781-7. PubMed ID: 18253145 [TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics, race, and psychiatry: prospects and challenges. Jones DS; Perlis RH Harv Rev Psychiatry; 2006; 14(2):92-108. PubMed ID: 16603475 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics in solid organ transplantation: current status and future directions. de Jonge H; Kuypers DR Transplant Rev (Orlando); 2008 Jan; 22(1):6-20. PubMed ID: 18631854 [TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics and pharmacogenomics: a clinical reality. Ferraldeschi R; Newman WG Ann Clin Biochem; 2011 Sep; 48(Pt 5):410-7. PubMed ID: 21733927 [TBL] [Abstract][Full Text] [Related]
8. Protein therapeutics: new applications for pharmacogenetics. Krejsa C; Rogge M; Sadee W Nat Rev Drug Discov; 2006 Jun; 5(6):507-21. PubMed ID: 16763661 [TBL] [Abstract][Full Text] [Related]
9. Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcome. Mourad M; Wallemacq P; De Meyer M; Malaise J; De Pauw L; Eddour DC; Goffin E; Lerut J; Haufroid V Transplantation; 2008 Apr; 85(7 Suppl):S19-24. PubMed ID: 18401258 [TBL] [Abstract][Full Text] [Related]
10. The Affymetrix DMET platform and pharmacogenetics in drug development. Deeken J Curr Opin Mol Ther; 2009 Jun; 11(3):260-8. PubMed ID: 19479659 [TBL] [Abstract][Full Text] [Related]
11. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics. Owen RP; Altman RB; Klein TE Hum Mutat; 2008 Apr; 29(4):456-60. PubMed ID: 18330919 [TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics in gastrointestinal disorders. Camilleri M; Saito YA Methods Mol Biol; 2008; 448():395-412. PubMed ID: 18370239 [TBL] [Abstract][Full Text] [Related]
16. [Hypersensitivity syndrome--the role of pharmacogenetics for prediction of efficacy and safety of antiretroviral therapy in patients with HIV/AIDS]. Cholewińska G Przegl Epidemiol; 2008; 62(1):149-54. PubMed ID: 18536238 [TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics and the potential for the individualization of antiretroviral therapy. Phillips EJ; Mallal SA Curr Opin Infect Dis; 2008 Feb; 21(1):16-24. PubMed ID: 18192781 [TBL] [Abstract][Full Text] [Related]
18. Evolution of pharmacogenomics. Somogy A Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663 [TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics of autoimmune diseases: research issues in the case of Multiple Sclerosis and the role of IFN-beta. Macciardi F; Martinelli Boneschi F; Cohen D J Autoimmun; 2005; 25 Suppl():1-5. PubMed ID: 16311019 [TBL] [Abstract][Full Text] [Related]